Sanofi's Gaucher Initiative Marks 25 Years Of Rare Disease Care In Egypt
Sanofi, through its philanthropic organisation Foundation S, is celebrating the 25th anniversary of The Gaucher Initiative, a ...
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...
MSCS joins "mass action" suit against drug companies over insulin costs
Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...
Sanofi Partners With Beano & Breakthrough T1D UK to Raise Awareness of autoimmune Type 1 Diabetes
T1D is an autoimmune, complex, and lifelong condition – and it can happen to anyone at any age even without family history.[1 ...
Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development
Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...
Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis
Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...
Daily7d
Sanofi, Regeneron Dupixent approved in EU for young children with eosinophilic esophagitis
Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...
PMLiVE7d
Sanofi/Regeneron’s Dupixent approved by EC for younger eosinophilic oesophagitis patients
Sanofi and Regeneron’s Dupixent (dupilumab ... by the regulator to treat EoE in patients aged 12 years and older, is now the ...
EurekAlert!15d
Insilico Medicine achieves a milestone in AI-facilitated drug discovery collaboration with Sanofi
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today ...